MassChallenge Startups Create Impact


Startups Accelerated


Funding Raised


Revenue Generated


Jobs Created

Our startups

Be inspired. Search our startups.


Each year, 4 million cataract surgeries are performed in the US. At a reimbursement rate of $1,000 per lens, the potential annual market for Adaptilens is $4 billion. An injectable, physiologically adaptive intraocular lens, Adaptilens will be superior to other lenses because it will be made of flexible polymers, will function most like the natural lens, will be easy to insert during cataract surgery, and won't shift inside the capsular bag postoperatively. The Company holds US Patent 10,278,810
Adaptilens will mimic the natural human lens so that patients will have clear distance and near vision without eyeglasses or contact lenses.

Connect with Adaptilens



2020 Finalist Boston

Sub industry

Medical Devices

Additional Industries
Therapeutics (Pharma / Biotech)
Public Health


MassChallenge strengthens the global innovation ecosystem by accelerating high-potential startups across all industries, from anywhere in the world.